Chemotherapy Combination Outcomes Differ For Aged, Younger Colon Cancer Patients

The combination of chemotherapies 5FU and oxaliplatin compared to 5FU alone after surgery for colon cancer decreases colon cancer recurrence and promotes longer survival for patients under 70 -- but not for those who are older, according to new findings.

Read the whole article on Science Daily

More from Science Daily